Dr Gavin L Noble, MD - Medicare Cardiovascular Disease (cardiology) in Brandon, VT

Dr Gavin L Noble, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in Brandon, Vermont. He went to State University Of Ny Upstate Medical University and graduated in 1999 and has 25 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Porter Hospital Inc, University Of Vermont Medical Center Inc and his current practice location is 61 Court Dr, Brandon, Vermont. You can reach out to his office (for appointments etc.) via phone at (802) 382-3443.

Dr Gavin L Noble is licensed to practice in Oregon (license number MD26753) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1750335014.

Contact Information

Dr Gavin L Noble, MD
61 Court Dr,
Brandon, VT 05733-8407
(802) 382-3443
Not Available



Physician's Profile

Full NameDr Gavin L Noble
GenderMale
SpecialityCardiovascular Disease (cardiology)
Experience25 Years
Location61 Court Dr, Brandon, Vermont
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Gavin L Noble attended and graduated from State University Of Ny Upstate Medical University in 1999
  NPI Data:
  • NPI Number: 1750335014
  • Provider Enumeration Date: 05/20/2006
  • Last Update Date: 07/11/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 6002861804
  • Enrollment ID: I20151013001186

Medical Identifiers

Medical identifiers for Dr Gavin L Noble such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1750335014NPI-NPPES
028459MedicaidOR
00397411OtherORMEDICARE RAILROAD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0000XInternal Medicine - Cardiovascular Disease 042-0013148 (Vermont)Secondary
174400000XSpecialist MD26753 (Oregon)Secondary
207R00000XInternal Medicine MD26753 (Oregon)Secondary
207RC0000XInternal Medicine - Cardiovascular Disease MD26753 (Oregon)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Porter Hospital, IncMiddlebury, VTHospital
Univ. Of Vermont - Fletcher Allen Health CareBurlington, VTHospital
Elizabethtown Community HospitalElizabethtown, NYHospital
Northwestern Medical Center IncSaint albans, VTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Porter Hospital Inc185036518059
University Of Vermont Medical Center Inc3779491071994

News Archive

New regulation for cancer-causing protein may help develop targeted therapies

Researchers with the Cincinnati Cancer Center (CCC) and the University of Cincinnati (UC) Cancer Institute have discovered a new regulation for the cancer-causing protein KRas which may help with the development of targeted therapies for patients with a KRas mutation.

Jeffrey Bethune files lawsuit against Bristol-Myers Squibb for denying overtime pay

Former pharmaceutical representative Jeffrey Bethune today filed a lawsuit in federal court in Manhattan against Bristol-Myers Squibb Company (BMS), charging the giant drug corporation with illegally denying him compensation for overtime hours.

Researchers find mutations in a multifunctional protein cause Parkinsonism

A team of researchers at Mayo Clinic in Jacksonville, Fla. and colleagues in Canada and Germany have discovered a gene and six mutations of it that cause symptoms associated with Parkinson's disease and other neurodegenerative disorders.

New research on epigenetics of lactose intolerance unravels understanding of schizophrenia

A new study on the epigenetics of lactose intolerance may provide an approach to understanding schizophrenia and other complex, serious illnesses

Haemacure obtains authorization to sell assets to Angiotech Pharmaceuticals

Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Gavin L Noble allows following entities to bill medicare on his behalf.
Entity NameUniversity Of Vermont Medical Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659309615
PECOS PAC ID: 3779491071
Enrollment ID: O20040406001047

News Archive

New regulation for cancer-causing protein may help develop targeted therapies

Researchers with the Cincinnati Cancer Center (CCC) and the University of Cincinnati (UC) Cancer Institute have discovered a new regulation for the cancer-causing protein KRas which may help with the development of targeted therapies for patients with a KRas mutation.

Jeffrey Bethune files lawsuit against Bristol-Myers Squibb for denying overtime pay

Former pharmaceutical representative Jeffrey Bethune today filed a lawsuit in federal court in Manhattan against Bristol-Myers Squibb Company (BMS), charging the giant drug corporation with illegally denying him compensation for overtime hours.

Researchers find mutations in a multifunctional protein cause Parkinsonism

A team of researchers at Mayo Clinic in Jacksonville, Fla. and colleagues in Canada and Germany have discovered a gene and six mutations of it that cause symptoms associated with Parkinson's disease and other neurodegenerative disorders.

New research on epigenetics of lactose intolerance unravels understanding of schizophrenia

A new study on the epigenetics of lactose intolerance may provide an approach to understanding schizophrenia and other complex, serious illnesses

Haemacure obtains authorization to sell assets to Angiotech Pharmaceuticals

Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.

Read more Medical News

› Verified 3 days ago

Entity NamePorter Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1053331389
PECOS PAC ID: 1850365180
Enrollment ID: O20050919000670

News Archive

New regulation for cancer-causing protein may help develop targeted therapies

Researchers with the Cincinnati Cancer Center (CCC) and the University of Cincinnati (UC) Cancer Institute have discovered a new regulation for the cancer-causing protein KRas which may help with the development of targeted therapies for patients with a KRas mutation.

Jeffrey Bethune files lawsuit against Bristol-Myers Squibb for denying overtime pay

Former pharmaceutical representative Jeffrey Bethune today filed a lawsuit in federal court in Manhattan against Bristol-Myers Squibb Company (BMS), charging the giant drug corporation with illegally denying him compensation for overtime hours.

Researchers find mutations in a multifunctional protein cause Parkinsonism

A team of researchers at Mayo Clinic in Jacksonville, Fla. and colleagues in Canada and Germany have discovered a gene and six mutations of it that cause symptoms associated with Parkinson's disease and other neurodegenerative disorders.

New research on epigenetics of lactose intolerance unravels understanding of schizophrenia

A new study on the epigenetics of lactose intolerance may provide an approach to understanding schizophrenia and other complex, serious illnesses

Haemacure obtains authorization to sell assets to Angiotech Pharmaceuticals

Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.

Read more Medical News

› Verified 3 days ago

Entity NamePorter Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134457013
PECOS PAC ID: 1850365180
Enrollment ID: O20050919000862

News Archive

New regulation for cancer-causing protein may help develop targeted therapies

Researchers with the Cincinnati Cancer Center (CCC) and the University of Cincinnati (UC) Cancer Institute have discovered a new regulation for the cancer-causing protein KRas which may help with the development of targeted therapies for patients with a KRas mutation.

Jeffrey Bethune files lawsuit against Bristol-Myers Squibb for denying overtime pay

Former pharmaceutical representative Jeffrey Bethune today filed a lawsuit in federal court in Manhattan against Bristol-Myers Squibb Company (BMS), charging the giant drug corporation with illegally denying him compensation for overtime hours.

Researchers find mutations in a multifunctional protein cause Parkinsonism

A team of researchers at Mayo Clinic in Jacksonville, Fla. and colleagues in Canada and Germany have discovered a gene and six mutations of it that cause symptoms associated with Parkinson's disease and other neurodegenerative disorders.

New research on epigenetics of lactose intolerance unravels understanding of schizophrenia

A new study on the epigenetics of lactose intolerance may provide an approach to understanding schizophrenia and other complex, serious illnesses

Haemacure obtains authorization to sell assets to Angiotech Pharmaceuticals

Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gavin L Noble is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Gavin L Noble, MD
1501 Ne Medical Center Dr,
Bend, OR 97701-6051

Ph: (541) 382-2811
Dr Gavin L Noble, MD
61 Court Dr,
Brandon, VT 05733-8407

Ph: (802) 382-3443

News Archive

New regulation for cancer-causing protein may help develop targeted therapies

Researchers with the Cincinnati Cancer Center (CCC) and the University of Cincinnati (UC) Cancer Institute have discovered a new regulation for the cancer-causing protein KRas which may help with the development of targeted therapies for patients with a KRas mutation.

Jeffrey Bethune files lawsuit against Bristol-Myers Squibb for denying overtime pay

Former pharmaceutical representative Jeffrey Bethune today filed a lawsuit in federal court in Manhattan against Bristol-Myers Squibb Company (BMS), charging the giant drug corporation with illegally denying him compensation for overtime hours.

Researchers find mutations in a multifunctional protein cause Parkinsonism

A team of researchers at Mayo Clinic in Jacksonville, Fla. and colleagues in Canada and Germany have discovered a gene and six mutations of it that cause symptoms associated with Parkinson's disease and other neurodegenerative disorders.

New research on epigenetics of lactose intolerance unravels understanding of schizophrenia

A new study on the epigenetics of lactose intolerance may provide an approach to understanding schizophrenia and other complex, serious illnesses

Haemacure obtains authorization to sell assets to Angiotech Pharmaceuticals

Haemacure Corporation announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a secured creditor of Haemacure. The United States Bankruptcy Court previously authorized the sale to Angiotech of the assets of Haemacure's U.S. subsidiary.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Brandon, VT

John F Dick Ii, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 420 Grove St, Brandon, VT 05733
Phone: 802-247-6305    Fax: 802-247-6040

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.